Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (as)
Status: Enrolling
Updated:  3/4/2015
Oregon Health and Science University
mi
from
Portland, OR
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (as)
Status: Enrolling
Updated: 3/4/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (as)
Status: Enrolling
Updated:  3/4/2015
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (as)
Status: Enrolling
Updated: 3/4/2015
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (as)
Status: Enrolling
Updated:  3/4/2015
Seattle Rheumatology Associates
mi
from
Seattle, WA
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (as)
Status: Enrolling
Updated: 3/4/2015
Seattle Rheumatology Associates
mi
from
Seattle, WA
Click here to add this to my saved trials
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (as)
Status: Enrolling
Updated:  3/4/2015
Arthritis Northwest
mi
from
Spokane, WA
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Of The Efficacy And Safety Of Tofacitinib In Subjects With Active Ankylosing Spondylitis (as)
Status: Enrolling
Updated: 3/4/2015
Arthritis Northwest
mi
from
Spokane, WA
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
Functional Research LLC
mi
from
Gulf Shores, AL
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
Functional Research LLC
mi
from
Gulf Shores, AL
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
Tucson Orthopaedic Institute
mi
from
Tucson, AZ
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
Tucson Orthopaedic Institute
mi
from
Tucson, AZ
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
Sc Clinical Research, Inc.
mi
from
Garden Grove, CA
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
Sc Clinical Research, Inc.
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
Axis Clinical Trials
mi
from
Los Angeles, CA
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
Axis Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
Westlake Medical Research
mi
from
Thousand Oaks, CA
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
Westlake Medical Research
mi
from
Thousand Oaks, CA
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
SC Clinical Research Inc.
mi
from
Upland, CA
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
SC Clinical Research Inc.
mi
from
Upland, CA
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
Schrock Orthopedics Research
mi
from
Ft Lauderdale, FL
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
Schrock Orthopedics Research
mi
from
Ft Lauderdale, FL
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
AppleMed Research Inc.
mi
from
Miami, FL
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
AppleMed Research Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
Radiant Research, Inc.
mi
from
Pinellas Park, FL
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
Radiant Research, Inc.
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
Beacon Clinical
mi
from
Brockton, MA
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
Beacon Clinical
mi
from
Brockton, MA
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
Radiant Research - Columbus
mi
from
Columbus, OH
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
Radiant Research - Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
Hillcrest Clinical Research
mi
from
Olahoma City, OK
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
Hillcrest Clinical Research
mi
from
Olahoma City, OK
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
PMG Research of Knoxville
mi
from
Knoxville, TN
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
PMG Research of Knoxville
mi
from
Knoxville, TN
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
PMG Research of Knoxville
mi
from
Knoxville, TN
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
PMG Research of Knoxville
mi
from
Knoxville, TN
Click here to add this to my saved trials
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated:  3/4/2015
Tekton Research
mi
from
Austin, TX
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
A Multicenter, Randomized, Double Blind, Active Controlled, Parallel Group, Clinical Study, to Evaluate the Safety and Efficacy of Apitox vs Histamine in Subjects With Refractory Osteoarthritis Pain and Inflammation of the Knee
Status: Enrolling
Updated: 3/4/2015
Tekton Research
mi
from
Austin, TX
Click here to add this to my saved trials
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  4/17/2015
Clinical Research Facility
mi
from
Crestview Hills, KY
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 4/17/2015
Clinical Research Facility
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  4/17/2015
Clinical Research Facility
mi
from
Omaha, NE
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 4/17/2015
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  4/17/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 4/17/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  4/17/2015
Clinical Research Facility
mi
from
Greensboro, NC
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 4/17/2015
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  4/17/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 4/17/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  4/17/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 4/17/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  4/17/2015
Clinical Research Facility
mi
from
Columbus, OH
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 4/17/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  4/17/2015
Clinical Research Facility
mi
from
Duncansville, PA
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 4/17/2015
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  4/17/2015
Clinical Research Facility
mi
from
Plano, TX
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 4/17/2015
Clinical Research Facility
mi
from
Plano, TX
Click here to add this to my saved trials
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated:  4/17/2015
Clinical Research Facility
mi
from
Charlottesville, VA
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
A Phase 2b, Multicenter, Randomized, Single Blind, Fixed Dose, Parallel Group Study to Evaluate the Efficacy and Safety of Meloxicam SoluMatrix® [Test] Capsules and Meloxicam Tablets in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 4/17/2015
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis
Addition of H. P Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis Inadequately Controlled With Biologic Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated:  4/30/2015
Phase III Clinical Research
mi
from
Fall River, MA
Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis
Addition of H. P Acthar Gel to Treatment Regimen of Patients With Rheumatoid Arthritis Inadequately Controlled With Biologic Disease-Modifying Antirheumatic Drugs
Status: Enrolling
Updated: 4/30/2015
Phase III Clinical Research
mi
from
Fall River, MA
Click here to add this to my saved trials
Study of Venous Endothelial Cells in Rheumatoid Arthritis
Analysis of Endothelial Cells in Rheumatoid Arthritis
Status: Enrolling
Updated:  6/8/2015
Parkland Memorial Hospital
mi
from
Dallas, TX
Study of Venous Endothelial Cells in Rheumatoid Arthritis
Analysis of Endothelial Cells in Rheumatoid Arthritis
Status: Enrolling
Updated: 6/8/2015
Parkland Memorial Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Venous Endothelial Cells in Rheumatoid Arthritis
Analysis of Endothelial Cells in Rheumatoid Arthritis
Status: Enrolling
Updated:  6/8/2015
University of Texas Southwestern
mi
from
Dallas, TX
Study of Venous Endothelial Cells in Rheumatoid Arthritis
Analysis of Endothelial Cells in Rheumatoid Arthritis
Status: Enrolling
Updated: 6/8/2015
University of Texas Southwestern
mi
from
Dallas, TX
Click here to add this to my saved trials
Study Comparing Fit of the iTotal Versus Standard Total Knee Implants
Study Comparing Fit of the iTotal Versus Standard Total Knee Implants
Status: Enrolling
Updated:  6/18/2015
JFK Medical Center
mi
from
Atlantis, FL
Study Comparing Fit of the iTotal Versus Standard Total Knee Implants
Study Comparing Fit of the iTotal Versus Standard Total Knee Implants
Status: Enrolling
Updated: 6/18/2015
JFK Medical Center
mi
from
Atlantis, FL
Click here to add this to my saved trials
Assessment of Efficacy of Low Intensity Resistance Training in Women at Risk for Symptomatic Knee Osteoarthritis
Assessment of Efficacy of Low Intensity Resistance Training in Women at Risk for Symptomatic Knee Osteoarthritis
Status: Enrolling
Updated:  7/2/2015
University of Iowa
mi
from
Iowa City, IA
Assessment of Efficacy of Low Intensity Resistance Training in Women at Risk for Symptomatic Knee Osteoarthritis
Assessment of Efficacy of Low Intensity Resistance Training in Women at Risk for Symptomatic Knee Osteoarthritis
Status: Enrolling
Updated: 7/2/2015
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Ultrasound (US)-Guided Versus Sham Ultrasound Corticosteroid (CS) Knee Injections
Ultrasound-guided Versus Sham Ultrasound Corticosteroid Knee Injections
Status: Enrolling
Updated:  7/5/2015
West Haven Veteran's Administration Medical Center
mi
from
West Haven, CT
Ultrasound (US)-Guided Versus Sham Ultrasound Corticosteroid (CS) Knee Injections
Ultrasound-guided Versus Sham Ultrasound Corticosteroid Knee Injections
Status: Enrolling
Updated: 7/5/2015
West Haven Veteran's Administration Medical Center
mi
from
West Haven, CT
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
Jackson, MS
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
Dallas, TX
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
Peoria, AZ
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
Scottsdale, AZ
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
Tucson, AZ
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
Fullerton, CA
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
Fullerton, CA
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
San Diego, CA
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
San Leandro, CA
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
San Leandro, CA
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
West Hills, CA
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
West Hills, CA
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
Trumbull, CT
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
Trumbull, CT
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
Boca Raton, FL
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
Jupiter, FL
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
Jupiter, FL
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
Ormond Beach, FL
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
Sarasota, FL
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated:  7/7/2015
Clinical Research Facility
mi
from
Gainesville, GA
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Status: Enrolling
Updated: 7/7/2015
Clinical Research Facility
mi
from
Gainesville, GA
Click here to add this to my saved trials